ACC Clinical Trials

570 recruitingLast updated: June 18, 2026

There are 570 actively recruiting acc clinical trials across 84 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1. Top locations include New York, New York, United States, Philadelphia, Pennsylvania, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


ACC Trials at a Glance

570 actively recruiting trials for acc are listed on ClinicalTrialsFinder across 6 cities in 84 countries. The largest study group is Not Applicable with 280 trials, with the heaviest enrollment activity in New York, Philadelphia, and Houston. Lead sponsors running acc studies include University of California, San Francisco, Johns Hopkins University, and Johns Hopkins Bloomberg School of Public Health.

Treatments under study

About ACC Clinical Trials

Looking for clinical trials for ACC? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ACC trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ACC clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 570 trials

Recruiting
Phase 1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Adrenocortical Carcinoma (ACC)Carcinoma, AdrenocorticalCarcinoma, Adrenal Cortical+2 more
National Cancer Institute (NCI)32 enrolled1 locationNCT06487481
Recruiting
Phase 1Phase 2

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more
Dren Bio200 enrolled37 locationsNCT05475925
Recruiting
Phase 4

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

PregnancyHealthyRSV+1 more
Canadian Immunization Research Network60 enrolled4 locationsNCT07097012
Recruiting
Not Applicable

Pivotal Study of the Velocity™ pAVF System

Chronic Kidney DiseaseEnd Stage Renal Disease (ESRD)Hemodialysis Access+1 more
Venova Medical126 enrolled12 locationsNCT07153939
Recruiting

Natural History of Stroke: Cause and Development

Brain DiseaseVascular DiseasesIschemic Attack, Transient+2 more
National Institute of Neurological Disorders and Stroke (NINDS)4,000 enrolled3 locationsNCT00009243
Recruiting
Not Applicable

Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial

Transcatheter Aortic Valve Replacement (TAVR)Cerebral Vascular Accident (CVA)/Stroke
Resonova (Shanghai) Medtech Limited240 enrolled15 locationsNCT07648693
Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting
Not Applicable

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS

COPDSmokingTobacco Use
Philip Morris Products S.A.290 enrolled112 locationsNCT07108166
Recruiting
Not Applicable

Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care

Tobacco Use Cessation
University of Florida1,332 enrolled1 locationNCT05415761
Recruiting
Phase 2Phase 3

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Mucopolysaccharidosis IIIMPS IIIASanfilippo Syndrome+1 more
Ultragenyx Pharmaceutical Inc36 enrolled5 locationsNCT02716246
Recruiting
Not Applicable

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Breast CancerBreast NeoplasmSymptom Management+4 more
Dena h. Al-Tameemi130 enrolled1 locationNCT07273812
Recruiting
Not Applicable

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

Tobacco UseCigarette SmokingCigarette Smoking Behavior
Abramson Cancer Center at Penn Medicine472 enrolled1 locationNCT07199517
Recruiting

Mucopolysaccharidosis VII Disease Monitoring Program

Mucopolysaccharidosis VIIMPS VIIMPS 7+1 more
Ultragenyx Pharmaceutical Inc50 enrolled14 locationsNCT03604835
Recruiting
Phase 4

E-cigarette Cessation in Adults Who Co-use Cannabis

Tobacco Use DisorderNicotine Dependence
Medical University of South Carolina105 enrolled3 locationsNCT06688539
Recruiting
Not Applicable

Young Adult Tobacco/Nicotine and Cannabis Co-use

Tobacco Use DisorderNicotine Dependence
Medical University of South Carolina350 enrolled1 locationNCT06239350
Recruiting

Longitudinal Measurements of Visual Diet in Children

MyopiaVisual DietPupil+5 more
State University of New York College of Optometry60 enrolled1 locationNCT07642999
Recruiting

Development of a Qualitative Scale to Asses the Acceptability of Percutaneous Techniques. A Delphi Study

Acceptability of Percutaneous Interventions
Universidad de Zaragoza65 enrolled1 locationNCT07380100
Recruiting
Not Applicable

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

HPV Vaccination
University of Utah55 enrolled1 locationNCT07648953
Recruiting
Phase 2

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Colorectal, CancerCholangiocarcinomaColorectal Neoplasms+10 more
National Cancer Institute (NCI)70 enrolled1 locationNCT05286814
Recruiting
Phase 2

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Squamous Cell Carcinoma of the Head and NeckDrug TherapyOropharynx+2 more
National Cancer Institute (NCI)70 enrolled1 locationNCT06223568